Discontinuation report TARO-PREGABALIN
Report ID | 144544 |
Drug Identification Number | 02392852 |
Brand name | TARO-PREGABALIN |
Common or Proper name | PREGABALIN |
Company Name | SUN PHARMA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | PREGABALIN |
Strength(s) | 225MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2021-07-26 |
Remaining supply date | |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2021-08-24 | French | Compare |
v1 | 2021-08-24 | English | Compare |
Showing 1 to 2 of 2